Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

How Is DexCom's Stock Performance Compared to Other Medical Devices Stocks?

With a market cap of about $46.4 billion, DexCom, Inc. (DXCM) is a leading medical device company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Based in San Diego, California, the company designs and develops advanced CGM products to provide real-time glucose data and insights for both patients and healthcare providers.

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and DexCom fits this criterion perfectly. DexCom is renowned for its market-leading CGM systems like the Dexcom G6 and G7. The company has over 5,000 employees and operates globally with significant revenue from its innovative CGM technology and devices, which support hundreds of thousands of users worldwide.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.